Citigroup raised Amplifon shares to a buy rating.
4 reports, 1 independent
Updated Oct 31
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup raised Amplifon shares to a buy rating.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Morgan Stanley assumed coverage on Amplifon shares following Citigroup's buy rating upgrade.1 source
Citigroup raised Amplifon shares to a buy rating.1 source
Keep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Amplifon
British-Italian multinational hearing aid retail chain
Nothing else this week.
Related events
- Citigroup and Benchmark issued buy ratings for Strategy shares, while MarketBeat reported the consensus rating for the stock.
- Citigroup issued a neutral rating on Genpact shares, while TD Cowen reduced its price target and set a buy rating.
- Citigroup and Jefferies Financial Group raised their price targets and issued buy ratings for Beauty.
- Citigroup upgraded its target price and gave a buy rating for Fortrea.
- Jefferies, Citigroup, and Leerink Partners issued rating updates and price targets for Phathom Pharmaceuticals.
Coverage
Newest first; wire copies grouped- themarketsdaily.com
- themarketsdaily.comAmplifon (AMFPF) Projected to Release Quarterly Earnings on Thursday